Terilyn J. Monroe - 26 Feb 2024 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Chief People Officer
Signature
/s/ John G. Saia, as attorney-in-fact for Tarilyn J. Monroe
Issuer symbol
GH
Transactions as of
26 Feb 2024
Net transactions value
$0
Form type
4
Filing time
27 Feb 2024, 19:07:27 UTC
Previous filing
18 Jan 2024
Next filing
12 Nov 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH Stock Option (Right to Buy) Award $0 +78,204 $0.000000 78,204 26 Feb 2024 Common Stock 78,204 $20.14 Direct F1
transaction GH Restricted Stock Units Award $0 +52,136 $0.000000 52,136 26 Feb 2024 Common Stock 52,136 $0.000000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents a stock option granted on February 26, 2024 that vests over a three-year period. 33% of the shares subject to such award will vest on the one-year anniversary of January 2, 2024 and the remaining 67% of the shares vests in equal monthly installments over the remaining two-year period thereafter.
F2 This represents a restricted stock unit award granted on February 26, 2024 that vests over a three-year period. 33% of the shares subject to such award will vest on the one-year anniversary of January 15, 2024 and the remaining 67% of the shares vests annually over the remaining two-year period thereafter.
F3 Not applicable for Restricted Stock Units.